Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Regeneron, Sanofi Drug Delayed by Plant Snag
Investopedia
Thu, 12/1/16 - 04:33 pm
Tags:
Regeneron, Sanofi, Dupixent, drug manufacturing, Sarilumab
No early success for Regeneron, Sanofi in PhIII outcomes study for PCSK9 drug Praluent
Endpoints
Thu, 11/17/16 - 09:54 am
Tags:
Regeneron, Sanofi, Praluent, PCSK9 inhibitors
Regeneron tops 3Q profit forecasts
Yahoo/AP
Fri, 11/4/16 - 09:30 am
Tags:
Regeneron, earnings
These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
Stat
Fri, 10/28/16 - 10:07 am
Tags:
PCSK9 inhibitors, Amgen, Regeneron, Sanofi, Repatha, Praluent, statins
FDA places Regeneron and Teva's pain-drug study on hold
Yahoo/Reuters
Mon, 10/17/16 - 11:56 am
Tags:
FDA, Regeneron, Teva Pharmaceutical, lower back pain, fasinumab, clinical trials
Regeneron picks a new delivery tech in effort to upgrade flagship blockbuster Eylea
Endpoints
Thu, 10/13/16 - 10:41 am
Tags:
Regeneron, Eylea, Ocular Therapeutix, drug delivery
Is Another Blockbuster Drug on the Way for Regeneron Pharmaceuticals, Inc.?
Motley Fool
Mon, 10/10/16 - 09:03 am
Tags:
Regeneron, Dupixent, Sanofi, atopic dermatitis
Hard To See If Regeneron's Eylea Combo Study Failure Reads Through To Ophthotech's Fovista
Yahoo/Benzinga
Tue, 10/4/16 - 10:17 am
Tags:
Regeneron, Eylea, clinical trials, Ophthotech, Fovista
Regeneron's Eylea combination therapy fails mid-stage study
Yahoo/Reuters
Fri, 09/30/16 - 09:45 am
Tags:
Regeneron, Eylea, clinical trials, wet age-related macular degeneration
3 Critical FDA Decisions You Can't Afford to Miss
Motley Fool
Tue, 09/27/16 - 10:13 pm
Tags:
FDA, Orkambi, Vertex Pharmaceuticals, Roche, Tecentriq, Regeneron, Sanofi, Sarilumab
​FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme
Bizjournals.com
Mon, 09/26/16 - 09:45 am
Tags:
FDA, Sanofi Genzyme, Regeneron, Sarilumab, dupilumab, eczema, rheumatoid arthritis
Teva, Regeneron enter deal potentially worth up to $2.6 billion to develop pain therapy fasinumab
First Word Pharma
Tue, 09/20/16 - 11:11 am
Tags:
Teva Pharmaceutical, Regeneron, fasinumab, painkillers
Amgen, Sanofi and Regeneron trot out new PCSK9 data at European heart meeting
Fierce Pharma
Mon, 08/29/16 - 05:52 pm
Tags:
Amgen, Sanofi, Regeneron, PCSK9 inhibitors, Repatha, Praluent
These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year
Motley Fool
Sun, 08/28/16 - 10:07 am
Tags:
PCSK9 inhibitors, Amgen, Repatha, Regeneron, Praluent, Sanofi
Are PCSK9 meds worth the cost? Only if Amgen, Sanofi and Regeneron slash prices by two-thirds: JAMA
Fierce Pharma
Wed, 08/17/16 - 12:11 pm
Tags:
PCSK9 inhibitors, Amgen, Sanofi, Regeneron, Praluent, Repatha, JAMA, drug pricing
Amgen, Sanofi Cholesterol Drugs Not Cost-Effective, Study Says
Bloomberg
Tue, 08/16/16 - 04:34 pm
Tags:
Amgen, Sanofi, Regeneron, Praluent, Repatha
Eylea sales lift Regeneron's profit past estimates
Yahoo/Reuters
Thu, 08/4/16 - 10:01 am
Tags:
Regeneron, earnings, Eylea
Regeneron leaps into the blockbuster race to develop off-the-shelf immune cell cancer therapies
Endpoints
Tue, 08/2/16 - 09:00 am
Tags:
Regeneron, drug development, CAR-T, cancer immunotherapy, Adicet Bio
Six Major Biotech Acquisitions You Could See in 2016 (Part 2)
Forbes
Mon, 07/25/16 - 09:51 am
Tags:
biotech, M&A, Pfizer, Teva Pharmaceutical, Allergan, Shire, Portola Pharmaceuticals, Sanofi, Medivation, Regeneron, Biogen
What’s behind Regeneron’s Operating Efficiency?
Market Realist
Tue, 07/12/16 - 09:29 am
Tags:
Regeneron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.